Showing results (151-160 of 236) with videos related to
Sort By:
Pageof 24
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 22, 2021
Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antiviralsNatthaya Chuaypen, Salyavit Chittmittrapap, Anchalee Avihingsanon, et al.Applied Health Economics and Health Policy|February 10, 2022
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in ThailandPiyameth Dilokthornsakul, Ratree Sawangjit, Pisit Tangkijvanich, et al.The American Journal of Gastroenterology|January 29, 2025
Cost-Utility Analysis of Non-Invasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver DiseasePakanat Decharatanachart, Kittiyod Poovorawan, Pisit Tangkijvanich, et al.Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2022
Targeted Proteins Reveal Cathepsin D as a Novel Biomarker
in Differentiating Hepatocellular Carcinoma from Cirrhosis
and Other Liver CancersNatthaya Chuaypen, Supachaya Sriphoosanaphan, Athaya Vorasittha, et al.Scientific Reports|May 28, 2021
Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinomaPattapon Kunadirek, Chaiyaboot Ariyachet, Supachaya Sriphoosanaphan, et al.Plos One|March 21, 2024
Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in ThailandSupachaya Sriphoosanaphan, Witthawat Pantumongkol, Wantanee Kulpeng, et al.Bioorganic & Medicinal Chemistry|October 21, 2022
meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studiesPanupun Limpachayaporn, Sopon Nuchpun, Jitnapa Sirirak, et al.Peerj|October 1, 2019
Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis CKessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjaroen, et al.Journal of Gastroenterology and Hepatology|March 30, 2026
Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian CohortThananya Jinato, Masoumeh Sikaroodia, Patrick M Gilleveta, et al.Asian Pacific Journal of Cancer Prevention : APJCP|January 28, 2014
Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg)Salyavit Chittmittrapap, Thaweesak Chieochansin, Roongruedee Chaiteerakij, et al.Pageof 24